Metraipolis › archive › dc_4a040a72d1bb

The TAK-003 story: key decisions that shaped development of a tetravalent dengue vaccine — Europe PMC PMID:41629324

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41629324
DOI
10.1038/s41541-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-06T06:10:40.824Z
SHA-256 of the archived text
f7f3a04842de1d7d916ab2b51821eb4db59b295657bb0f01fe9f7b6e399b2561
Stable URL of this page
https://metraipolis.com/documento/dc_4a040a72d1bb

How to cite

The TAK-003 story: key decisions that shaped development of a tetravalent dengue vaccine — Europe PMC PMID:41629324 — Europe PMC (en), https://europepmc.org/article/MED/41629324 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4a040a72d1bb (Metraipolis archive dc_4a040a72d1bb, sha256 f7f3a04842de1d7d916ab2b51821eb4db59b295657bb0f01fe9f7b6e399b2561)
BibTeX
@misc{dc4a040a72d1bb,
  title = {The TAK-003 story: key decisions that shaped development of a tetravalent dengue vaccine — Europe PMC PMID:41629324},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41629324},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4a040a72d1bb; sha256 f7f3a04842de1d7d916ab2b51821eb4db59b295657bb0f01fe9f7b6e399b2561},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41629324. Agents can read the archived copy with the MCP tool read_document.